학술논문

M9657 Is a Bispecific Tumor-Targeted Anti-CD137 Agonist That Induces MSLN-Dependent Antitumor Immunity without Liver Inflammation
Document Type
Journal
Source
CANCER IMMUNOLOGY RESEARCH; FEB 2 2024, 12 2, p195-p213, 19p.
Subject
Language
English
ISSN
23266074